Published in Mol Med on March 02, 2006
PrP(Sc)-specific antibodies with the ability to immunodetect prion oligomers. PLoS One (2011) 0.82
PrP antibody binding-induced epitope modulation evokes immunocooperativity. J Neuroimmunol (2008) 0.80
A camelid anti-PrP antibody abrogates PrP replication in prion-permissive neuroblastoma cell lines. PLoS One (2010) 0.79
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature (1997) 15.73
Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature (1996) 14.40
The same prion strain causes vCJD and BSE. Nature (1997) 12.49
Mice devoid of PrP are resistant to scrapie. Cell (1993) 11.46
Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature (1992) 9.01
Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med (1998) 9.01
Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol (1987) 7.05
Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell (1990) 6.17
A novel progressive spongiform encephalopathy in cattle. Vet Rec (1987) 4.39
Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet (1997) 4.28
Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature (1997) 4.03
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet (1999) 4.02
Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci U S A (1993) 3.56
Bovine spongiform encephalopathy: epidemiological studies. Vet Rec (1988) 3.55
Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J Wildl Dis (1980) 3.53
A prion protein epitope selective for the pathologically misfolded conformation. Nat Med (2003) 3.41
A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J Mol Biol (1997) 2.95
Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins. Neurology (1990) 2.90
Preclinical diagnosis of scrapie by immunohistochemistry of third eyelid lymphoid tissue. J Clin Microbiol (2000) 2.63
Conformational Abs recognizing a generic amyloid fibril epitope. Proc Natl Acad Sci U S A (2002) 2.62
The prion diseases. Brain Pathol (1998) 2.20
Scrapie surveillance in Great Britain: results of an abattoir survey, 1997/98. Vet Rec (2000) 2.17
Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science (1999) 1.95
PrP protein is associated with follicular dendritic cells of spleens and lymph nodes in uninfected and scrapie-infected mice. J Pathol (1992) 1.79
Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie. Nat Med (2000) 1.78
T cell independent antigens. Curr Opin Immunol (1995) 1.78
Hypothesis: interference with axonal transport of neurofilament as a common pathogenetic mechanism in certain diseases of the central nervous system. N Engl J Med (1985) 1.73
Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system. Proc Natl Acad Sci U S A (1996) 1.60
Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides. Lancet (2000) 1.54
Synthetic peptide vaccines yield monoclonal antibodies to cellular and pathological prion proteins of ruminants. J Gen Virol (1998) 1.50
RNA aptamers specifically interact with the prion protein PrP. J Virol (1997) 1.43
Regional heterogeneity of cellular prion protein isoforms in the mouse brain. Brain (2003) 1.37
Tonsillar biopsy and PrPSc detection in the preclinical diagnosis of scrapie. Vet Rec (1998) 1.36
Failure to demonstrate a humoral immune response to scrapie infection in mice. J Immunol (1973) 1.30
Multiple folding pathways for heterologously expressed human prion protein. Biochim Biophys Acta (1999) 1.29
New monoclonal antibodies in CD44 and CD58: their use to quantify CD44 and CD58 on normal human erythrocytes and to compare the distribution of CD44 and CD58 in human tissues. Immunology (1991) 1.26
Immunologic and molecular biologic studies of prion proteins in bovine spongiform encephalopathy. J Infect Dis (1993) 1.24
Plasminogen binds to disease-associated prion protein of multiple species. Lancet (2001) 1.11
Induction of antibodies against human prion proteins (PrP) by DNA-mediated immunization of PrP0/0 mice. J Immunol Methods (1996) 0.99
Generation of monoclonal antibodies against prion proteins with an unconventional nucleic acid-based immunization strategy. J Biotechnol (1999) 0.97
Molecular biology and genetics of prion diseases. Philos Trans R Soc Lond B Biol Sci (1994) 0.95
Thermostability of mouse-passaged BSE and scrapie is independent of host PrP genotype: implications for the nature of the causal agents. J Gen Virol (2002) 0.91
Protein conformation dictates prion strain. Nat Med (1998) 0.87
Autoimmune T cells in myasthenia gravis: heterogeneity and potential for specific immunotargeting. Immunol Today (1996) 0.86
Creutzfeldt-Jakob disease and cerebral amyloid angiopathy. Acta Neuropathol (1994) 0.84
The use of transgenic mice in the investigation of transmissible spongiform encephalopathies. Rev Sci Tech (1998) 0.82
Stimulation of human T cells by sparse antigens captured on immunomagnetic particles. J Immunol Methods (1992) 0.80
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
TREM2 variants in Alzheimer's disease. N Engl J Med (2012) 11.35
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science (2003) 4.57
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet (2005) 4.21
Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science (2003) 3.59
Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet (2006) 3.12
BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J (2002) 2.98
Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science (2004) 2.82
Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature (2011) 2.74
Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain (2012) 2.65
Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet (2011) 2.60
Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron (2007) 2.58
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One (2010) 2.57
Autoantibodies in sporadic Creutzfeldt-Jakob disease. JAMA Neurol (2013) 2.42
Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain (2003) 2.42
Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature (2003) 2.31
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol (2010) 2.30
A systematic review of prion therapeutics in experimental models. Brain (2006) 2.25
A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain (2008) 2.13
Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am J Hum Genet (2013) 2.09
Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell (2007) 2.01
Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein. Lancet (2004) 1.96
Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites. Nat Commun (2011) 1.96
Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study. Lancet Neurol (2009) 1.94
Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrils. J Neurosci (2010) 1.92
Variant CJD in an individual heterozygous for PRNP codon 129. Lancet (2009) 1.84
Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J (2008) 1.77
Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc Natl Acad Sci U S A (2008) 1.71
A novel prion disease associated with diarrhea and autonomic neuropathy. N Engl J Med (2013) 1.69
A novel protective prion protein variant that colocalizes with kuru exposure. N Engl J Med (2009) 1.53
Update on human prion disease. Biochim Biophys Acta (2007) 1.46
Inherited prion disease with 4-octapeptide repeat insertion: disease requires the interaction of multiple genetic risk factors. Brain (2011) 1.45
Molecular and clinical classification of human prion disease. Br Med Bull (2003) 1.45
Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis. J Biol Chem (2005) 1.42
Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia. Acta Neuropathol (2013) 1.41
Atypical scrapie prions from sheep and lack of disease in transgenic mice overexpressing human prion protein. Emerg Infect Dis (2013) 1.38
Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice. Proc Natl Acad Sci U S A (2008) 1.37
Regional heterogeneity of cellular prion protein isoforms in the mouse brain. Brain (2003) 1.37
Subclinical prion infection. Trends Microbiol (2003) 1.36
Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations. Hum Mol Genet (2010) 1.35
Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function. J Clin Invest (2009) 1.35
The role of CHMP2B in frontotemporal dementia. Biochem Soc Trans (2009) 1.34
Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein. Brain (2006) 1.34
Identification of genetic loci affecting mouse-adapted bovine spongiform encephalopathy incubation time in mice. Neurogenetics (2002) 1.31
Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations. Brain (2006) 1.31
Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PLoS One (2010) 1.25
Subclinical prion infection in humans and animals. Br Med Bull (2003) 1.25
Characterization of two distinct prion strains derived from bovine spongiform encephalopathy transmissions to inbred mice. J Gen Virol (2004) 1.23
Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice. Proc Natl Acad Sci U S A (2006) 1.22
Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene. Arch Neurol (2008) 1.20
CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum Mol Genet (2007) 1.20
Chronic wasting disease prions are not transmissible to transgenic mice overexpressing human prion protein. J Gen Virol (2010) 1.19
HECTD2 is associated with susceptibility to mouse and human prion disease. PLoS Genet (2009) 1.18
Rational targeting for prion therapeutics. Nat Rev Neurosci (2005) 1.18
Mapping the progression of progranulin-associated frontotemporal lobar degeneration. Nat Clin Pract Neurol (2008) 1.17
Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins. J Gen Virol (2009) 1.16
Genetic variability in CLU and its association with Alzheimer's disease. PLoS One (2010) 1.16
Inherited prion disease with six octapeptide repeat insertional mutation--molecular analysis of phenotypic heterogeneity. Brain (2006) 1.15
The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPC. J Biol Chem (2004) 1.14
An enzyme-detergent method for effective prion decontamination of surgical steel. J Gen Virol (2005) 1.14
Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry. EMBO J (2011) 1.13
Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP. Hum Mol Genet (2011) 1.12
Molecular diagnosis of human prion disease. Methods Mol Biol (2008) 1.12
Genetics of prion disease. Top Curr Chem (2011) 1.11
Elongated oligomers assemble into mammalian PrP amyloid fibrils. J Mol Biol (2006) 1.10
PrP glycoforms are associated in a strain-specific ratio in native PrPSc. J Gen Virol (2005) 1.09
PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit. Hum Mutat (2010) 1.07
Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid. PLoS One (2010) 1.06
No association of PGRN 3'UTR rs5848 in frontotemporal lobar degeneration. Neurobiol Aging (2009) 1.05
Validation of next-generation sequencing technologies in genetic diagnosis of dementia. Neurobiol Aging (2013) 1.05
Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series. Neurobiol Aging (2010) 1.04
Highly sensitive, quantitative cell-based assay for prions adsorbed to solid surfaces. Proc Natl Acad Sci U S A (2009) 1.04
Successful amplification of degraded DNA for use with high-throughput SNP genotyping platforms. Hum Mutat (2008) 1.04
Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease. Philos Trans R Soc Lond B Biol Sci (2008) 1.03
Somatic and germline mosaicism in sporadic early-onset Alzheimer's disease. Hum Mol Genet (2004) 1.03
The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. J Alzheimers Dis (2012) 1.02
Prion diseases. J Neurovirol (2003) 1.02
Molecular pathology of human prion disease. Acta Neuropathol (2010) 1.01
Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration. Neurobiol Aging (2009) 1.01
Spontaneous generation of mammalian prions. Proc Natl Acad Sci U S A (2010) 1.00
Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicity. Nat Commun (2013) 1.00
PrPSc binding antibodies are potent inhibitors of prion replication in cell lines. J Biol Chem (2004) 0.99
Definable equilibrium states in the folding of human prion protein. Biochemistry (2005) 0.99
Heterozygosity at polymorphic codon 219 in variant creutzfeldt-jakob disease. Arch Neurol (2010) 0.99
Tau, prions and Aβ: the triad of neurodegeneration. Acta Neuropathol (2010) 0.99
Multiple forms of copper (II) co-ordination occur throughout the disordered N-terminal region of the prion protein at pH 7.4. Biochem J (2006) 0.98
Protein conformation significantly influences immune responses to prion protein. J Immunol (2005) 0.95
Preventing prion pathogenicity by targeting the cellular prion protein. Infect Disord Drug Targets (2009) 0.94
Effect of fixation on brain and lymphoreticular vCJD prions and bioassay of key positive specimens from a retrospective vCJD prevalence study. J Pathol (2010) 0.94
Discrimination between prion-infected and normal blood samples by protein misfolding cyclic amplification. Transfusion (2010) 0.94
A highly sensitive immunoassay for the detection of prion-infected material in whole human blood without the use of proteinase K. Transfusion (2010) 0.94
Folding kinetics of the human prion protein probed by temperature jump. Proc Natl Acad Sci U S A (2009) 0.94